DeepCurrents Investment Group »

Biomarin Pharmaceutical shares owned by DeepCurrents Investment Group

Quarter-by-quarter ownership of Biomarin Pharmaceutical shares owned by DeepCurrents Investment Group from 13F filings

Historical chart of DeepCurrents Investment Group investment in Biomarin Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including Biomarin Pharmaceutical held by DeepCurrents Investment Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biomarin Pharmaceutical by DeepCurrents Investment Group

Quarter filed Position value Share count Share price at filing
2026-03-31 $9.7M 10M 0.97

More positions owned by DeepCurrents Investment Group

Interdigital Note 3.500% 6/0 (Principal)
Netflix Call Option (NFLX)
Strategy Cl A New Put Option (MSTR)
Repligen Corp Note 1.000%12/1 (Principal)
Cloudflare Note 8/1 (Principal)
Ascendis Pharma A/s Note 2.250% 4/0 (Principal)
Draftkings Note 3/1 (Principal)
Workiva Note 1.250% 8/1 (Principal)
State Str Spdr S&p 500 Etf T Tr Unit Call Option (SPY)
Coinbase Global Note 0.500% 6/0 (Principal)
Strategy Note 0.625% 9/1 (Principal)
Teladoc Health Note 1.250% 6/0 (Principal)
Upwork Note 0.250% 8/1 (Principal)
Peabody Engr Corp Note 3.250% 3/0 (Principal)
Snowflake Note 10/0 (Principal)

View all positions for DeepCurrents Investment Group

Top funds holding Biomarin Pharmaceutical

Tenor Capital Management
Oaktree Capital Management
Capstone Investment Advisors
BlackRock
Man Group
Opti Capital Management
MacKay Shields
Lazard Asset Management
Toronto-Dominion Bank
Verition Fund Management
Victory Capital Management
Thrivent Financial for Lutherans
State Street Corporation
DeepCurrents Investment Group
Citigroup

View all funds holding Biomarin Pharmaceutical